JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome
K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of …
GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn… - Circulation, 2016 - Am Heart Assoc
The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …
[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
[HTML][HTML] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh… - … England Journal of …, 2014 - Mass Medical Soc
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised …
WJM Dewilde, T Oirbans, FWA Verheugt, JC Kelder… - The Lancet, 2013 - thelancet.com
Background If percutaneous coronary intervention (PCI) is required in patients taking oral
anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple …
anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple …
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial
F Feres, RA Costa, A Abizaid, MB Leon, JA Marin-Neto… - Jama, 2013 - jamanetwork.com
Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …
Drug-eluting coronary-artery stents
GG Stefanini, DR Holmes Jr - New England Journal of Medicine, 2013 - Mass Medical Soc
Drug-Eluting Coronary-Artery Stents | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Second-generation drug-eluting stent implantation followed by 6-versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial
A Colombo, A Chieffo, A Frasheri, R Garbo… - Journal of the American …, 2014 - jacc.org
Background: The optimal duration of dual antiplatelet therapy (DAPT) following second-
generation drug-eluting stent (DES) implantation is still debated. Objectives: The aim of this …
generation drug-eluting stent (DES) implantation is still debated. Objectives: The aim of this …